Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.

Multidrug-resistant (MDR) cell lines often have a compound phenotype, combining reduced drug accumulation with a decrease in topoisomerase II. We have analysed alterations in topoisomerase II in MDR derivatives of the human lung cancer cell line SW-1573. Selection with doxorubicin frequently resulte...

Descripción completa

Detalles Bibliográficos
Autores principales: Eijdems, E. W., de Haas, M., Timmerman, A. J., Van der Schans, G. P., Kamst, E., de Nooij, J., Astaldi Ricotti, G. C., Borst, P., Baas, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033439/
https://www.ncbi.nlm.nih.gov/pubmed/7819046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033439/
https://www.ncbi.nlm.nih.gov/pubmed/7819046

Ejemplares similares